Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Partners with Clinical Research Organization to Provide Pharmacogenomic Services

NEW YORK, June 7 (GenomeWeb News) - Genaissance Pharmaceuticals will provide pharmacogenomic services through clinical contract research organization INC Research, the company said today.

 

INC Research, based in Raleigh, NC, focuses on clinical research in oncology, pediatrics, and the central nervous system. Genaissance will offer pharmacogenetic clinical development sevices to INC's clients.

 

This is Genaissance's first partnership with a clinical research organization, according to the company.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.